Late Phase II clinical trial and discontinuation of development of KRP-N118
A standalone pharmaceutical development theme involving KRP-N118, for which development was discontinued after a late Phase II clinical trial because it was determined that the desired product profile would be difficult to achieve.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.